Published in Medicine and Law Weekly, February 17th, 2006
The lawsuit, filed in Massachusetts Superior Court, is in connection with the license agreement established between Cytogen and Advanced Magnetics in 2000, as amended, for both Combidex and ferumoxytol, previously Code 7228.
The complaint seeks damages along with a request for specific performance requiring Advanced Magnetics to take all reasonable steps to secure U.S. Food & Drug Administration approval of Combidex in compliance with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.